$24.67
-0.30-1.2%
al cierre: Sep 10, 5:00 PM EST
$24.60
-0.37-1.48%
Premercado: 7:08 AM EST

Immunome (IMNM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.51 | $-0.56 | $-0.60 | $-0.55 |
| Actual | $-0.65 | $-0.48 | $-0.75 | $-0.65 |
| Surprise | -27.5% | +14.3% | -25.0% | -18.2% |
| Revenue | ||||
| Estimate | $533336 | $533336 | $784620 | $727270 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.60 | $-0.62 | $-0.69 | $-0.72 |
| Revenue | ||||
| Consensus | $533336 | $533336 | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.65 | $-0.51 | -27.5 % |
| Q1 | May 12, 2026 | $-0.48 | $-0.56 | 14.3 % |
| Q4 | Mar 3, 2026 | $-0.75 | $-0.60 | -25.0 % |
| Q3 | Nov 6, 2025 | $-0.65 | $-0.55 | -18.2 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0 | $533.34K | -100.0 % |
| Q1 | May 12, 2026 | $0 | $533.34K | -100.0 % |
| Q4 | Mar 3, 2026 | $0 | $784.62K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $727.27K | -100.0 % |